{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Umadevi Thirumurthi"}, {"accession": "MS:1000589", "name": "contact email", "value": "Umadevi.Thirumurthi@uth.tmc.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "UT MD Anderson Cancer Center"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Mien-Chie Hung"}, {"accession": "MS:1000589", "name": "contact email", "value": "mhung@mdanderson.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "UT MD Anderson Cancer Center"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/07/PXD001154/Flag-SIRT6-P-p.raw"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/07/PXD001154/flag-SIRT6-S303-MSMS.jpg"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/07/PXD001154/flag-SIRT6-S338-MSMS.jpg"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/07/PXD001154/SIRT6-S330-p.jpg"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/07/PXD001154/SIRT6-p.xml"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/07/PXD001154/Flag-SIRT6-P-p.msm"}], "description": "Sirtuin 6 (SIRT6) is associated with longevity and was recently established as a tumor suppressor. Hence, identifying the molecular regulators of SIRT6 might enable its activation therapeutically in cancer patients. We found that SIRT6 was phosphorylated by the kinase AKT1 at Ser338, which induces its interaction with and ubiquitination by MDM2, priming it for protease-dependent degradation. The survival of patients with breast cancers positively correlated with the abundance of SIRT6 and inversely correlated with the phosphorylation of SIRT6 at Ser338. In a large panel of breast tumor biopsies, SIRT6 abundance inversely correlated with the abundance of phosphorylated AKT.  Inhibiting AKT or preventing SIRT6 phosphorylation by mutating Ser338 prevented the degradation of SIRT6 mediated by MDM2, suppressed the proliferation of breast cancer cells in culture, and inhibited the growth of breast tumor xenografts in mice. Overexpressing MDM2 decreased the abundance of SIRT6 in cells, whereas overexpressing an E3 ligase-deficient MDM2 or knocking down endogenous MDM2 increased SIRT6 abundance. Knocking down SIRT6 decreased the sensitivity of a breast cancer cell line to trastuzumab, whereas overexpression of a non-phosphorylatable SIRT6 mutant increased trastuzumab sensitivity in a resistant subculture. Thus, stabilizing SIRT6 may be a clinical strategy for overcoming trastuzumab resistance in breast cancer patients.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/07/PXD001154"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD001154"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD001154"}], "instruments": [{"accession": "MS:1000187", "name": "Q TRAP"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "SIRT6, phosphorylation"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Biology/Disease-Driven Human Proteome Project (B/D-HPP)"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Human Proteome Project"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "25074979"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Thirumurthi U, Shen J, Xia W, LaBaff AM, Wei Y, Li CW, Chang WC, Chen CH, Lin HK, Yu D, Hung MC. MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Sci Signal. 2014 Jul 29;7(336):ra71"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "SIRT6 phosphorylation"}